References for Anti-mouse PD-1 Monoclonal Antibody (Clone RMP1-14)

References for Anti-mouse PD-1 monoclonal antibody (Clone RMP1-14) are as follows:

1.Myeloid Antigen-Presenting Cell Niches Sustain Antitumor T Cells and License PD-1 Blockade via CD28 Costimulation
2.Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs
3.Immune receptor inhibition through enforced phosphatase recruitment
4.Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells
5.Angiogenic inhibitor pre‐administration improves the therapeutic effects of immunotherapy
6.Sources of inter-individual variability leading to significant changes in anti-PD-1 and anti-PD-L1 efficacy identified in mouse tumor models using a QSP framework
7.Targeting PD-L2/RGMb overcomes microbiome-related immunotherapy resistance
8.Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
9.Antibody-mediated depletion of programmed death 1-positive (PD-1+) cells
10.Synergistic anticancer activity of a novel oral chemotherapeutic agent containing trifluridine and tipiracil in combination with anti-PD-1 blockade in microsatellite stable-type murine colorectal cancer cells
11.Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinoma
12.Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity
13.Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells
14.Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia
15.Diphtheria toxin‐derived, anti‐PD‐1 immunotoxin, a potent and practical tool to selectively deplete PD‐1+ cells
16.Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues
17.Prophylactic IL-23 blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
18.Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain
19.PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration
20.PD-L1/PD-1 checkpoint pathway regulates hippocampal neuronal excitability and learning and memory behavior
……
……

References for Recombinant Anti-mouse PD-1 Monoclonal Antibody will be continuously updated.

Recombinant Anti-mouse PD-1 Monoclonal Antibody (Clone RMP1-14.1) of Syd Labs:

Syd Labs’ Recombinant Anti-mouse PD-1 Monoclonal Antibody (Clone RMP1-14.1), Rat IgG2a Kappa, In Vivo Grade (Catalog No.: PA007162.r2a) is a recombinant antibody produced in mammalian cells. It shares the same variable region sequence as the rat anti-mouse PD-1 antibody (Clone RMP1-14) and is suitable for applications including immunohistochemistry (IHC), flow cytometry (FC), and various in vitro and in vivo functional assays, such as animal studies.
For more information about Syd Labs’ Recombinant Anti-mouse PD-1 Monoclonal Antibody (Clone RMP1-14.1), including usage instructions, please contact Ushelf for assistance.